AC
PRAH

Ascend Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ascend Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,174
Closed -$563K – 287
2017
Q4 		$563K Buy
+6,174
New +$514K 0.02% 198

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ascend Capital's PRAH Position: Q1 2018 in Review

Ascend Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 6,174 shares — an estimated $563K sold.

Ascend Capital first reported a position in PRAH in Q4 2017 and held it in 1 quarter. The position peaked at $563K in Q4 2017. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

  • Ascend Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • Ascend Capital sold 6,174 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $563K.
  • Ascend Capital first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 1 quarter.
  • Ascend Capital's PRA Health Sciences, Inc. position peaked at $563K in Q4 2017.
  • 278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.